(Q37793823)

23 August 2017

title

Childhood craniopharyngioma--current concepts in diagnosis, therapy and follow-up (English)

1 reference

23 August 2017

0 references

1 reference

Hermann L Müller

1

1 reference

23 August 2017

publication date

28 September 2010

1 reference

Nature Reviews Endocrinology

23 August 2017

published in

1 reference

23 August 2017

volume

6

1 reference

23 August 2017

issue

11

1 reference

23 August 2017

page(s)

609-618

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2010.168

23 August 2017

exact match

0 references

cites work

Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Craniopharyngioma: the St. Jude Children's Research Hospital experience 1984-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Combined proton and photon irradiation for craniopharyngioma: long-term results of the early cohort of patients treated at Harvard Cyclotron Laboratory and Massachusetts General Hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

More or less? Treatment strategies in childhood craniopharyngioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Craniopharyngioma: modern concepts in pathogenesis and treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Radical surgery in a neonate with craniopharyngioma. report of a case.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Beta-catenin mutations in craniopharyngiomas and pituitary adenomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

beta-Catenin is expressed aberrantly in tumors expressing shadow cells. Pilomatricoma, craniopharyngioma, and calcifying odontogenic cyst

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: a clinico-pathologic approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Functional capacity and body mass index in patients with sellar masses--cross-sectional study on 403 patients diagnosed during childhood and adolescence.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Differential diagnosis of suprasellar tumors in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Imaging of sellar and parasellar lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Surgical treatment of craniopharyngiomas: experience with 168 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

The role of radiotherapy in the treatment of craniopharyngioma--indications, results, side effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Efficacy and safety of radical resection of primary and recurrent craniopharyngiomas in 86 children.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Recurrence in craniopharyngiomas: analysis of clinical and histological features.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Craniopharyngioma and hypothalamic obesity in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Craniopharyngiomas in children. Long-term effects of conservative surgical procedures combined with radiation therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

20-year experience in childhood craniopharyngioma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Craniopharyngioma--a long-term results following limited surgery and radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Craniopharyngiomas in children: surgical experience at Children's Memorial Hospital.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Neurosurgical treatment strategies in childhood craniopharyngiomas: is less more?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Analyses of treatment variables for patients with childhood craniopharyngioma--results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Craniopharyngioma: results of survey of the American Society of Pediatric Neurosurgery.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

[Munster Heidelberg Abilities Scale--a measuring instrument for global comparison of illness sequelae]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Achievement of long-term local control in patients with craniopharyngiomas using high precision stereotactic radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Tolerance of the optic apparatus in single-fraction irradiation using stereotactic radiosurgery: evaluation in 100 patients with craniopharyngioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Long-term results of gamma knife radiosurgery for 100 consecutive cases of craniopharyngioma and a treatment strategy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Long-term results and late complications after intracavitary yttrium-90 colloid irradiation of recurrent cystic craniopharyngiomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Pathological findings in cystic craniopharyngiomas after stereotactic intracavitary irradiation with yttrium-90 isotope

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Use of bleomycin in intratumoral chemotherapy for cystic craniopharyngioma. Case report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Radiological findings following postsurgical intratumoral bleomycin injection for cystic craniopharyngioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Apoptosis in alpha interferon (IFN-alpha) intratumoral chemotherapy for cystic craniopharyngiomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Late neuropsychological and behavioural outcome of children surgically treated for craniopharyngioma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Social and psycho-intellectual outcome following radical removal of craniopharyngiomas in childhood. A prospective series.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Outcomes and failure patterns in childhood craniopharyngiomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Growth and endocrine sequelae of craniopharyngioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Radiation dose-volume effects on growth hormone secretion.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Surgical treatment of craniopharyngiomas: endocrinological results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

GH replacement does not increase the risk of recurrence in patients with craniopharyngioma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Risk factors for the development of obesity in children surviving brain tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Obesity after childhood craniopharyngioma - German multicenter study on pre-operative risk factors and quality of life

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Features of the metabolic syndrome after childhood craniopharyngioma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Volumetric bone mineral density in patients with childhood craniopharyngioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Perioperative dexamethasone treatment in childhood craniopharyngioma--influence on short-term and long-term weight gain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Sleep-disordered breathing is increased in obese adolescents with craniopharyngioma compared with obese controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Appetite-regulating hormone changes in patients with craniopharyngioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Changes of peripheral alpha-melanocyte-stimulating hormone in childhood obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Distal gastric bypass surgery for the treatment of hypothalamic obesity after childhood craniopharyngioma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Outcome after bariatric surgery in two adolescents with hypothalamic obesity following treatment of craniopharyngioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Prognosis and sequela in patients with childhood craniopharyngioma -- results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Quality of life in treated adult craniopharyngioma patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.168

Craniopharyngioma: ophthalmological aspects at diagnosis

31 March 2020

1 reference

12 December 2020

Current strategies in diagnostics and endocrine treatment of patients with childhood craniopharyngioma during follow-up--recommendations in KRANIOPHARYNGEOM 2000.

1 reference

12 December 2020

Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging

1 reference

12 December 2020

Neuroimaging of pediatric craniopharyngiomas: a pictorial essay.

1 reference

12 December 2020

Ciliated craniopharyngioma may arise from Rathke cleft cyst.

1 reference

12 December 2020

Radiation therapy in the management of craniopharyngioma: current concepts and future developments.

1 reference

12 December 2020

Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement

1 reference

12 December 2020

Fractionated proton radiation treatment for pediatric craniopharyngioma: preliminary report

1 reference

12 December 2020

Radical resection for craniopharyngiomas in children: surgical technique and clinical results.

1 reference

12 December 2020

Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up.

1 reference

12 December 2020

Quality of life and behavioral follow-up study of pediatric survivors of craniopharyngioma.

1 reference

12 December 2020

Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese childhood craniopharyngioma patients.

1 reference

12 December 2020

The descriptive epidemiology of craniopharyngioma

1 reference

12 December 2020

Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function.

1 reference

12 December 2020

Management of cystic craniopharyngiomas in childhood by a transsphenoidal approach

1 reference

12 December 2020

Consensus and perspectives on treatment strategies in childhood craniopharyngioma: results of a meeting of the Craniopharyngioma Study Group (SIOP), Genova, 2004

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2010.168

1 reference

23 August 2017

1 reference